The U.S. Food and Drug Administration staff said a two-dose regimen of Moderna’s vaccine has proved highly effective in preventing COVID-19 confirmed cases. The FDA reviewers did not raise any safety related issues for using Moderna’s COVID-19 vaccine in adults over the age18. They clearly said that no serious side effects has been seen in the general population in the study.
The United States has planned to deliver 40 million vaccine doses for 20 million people this month.
